ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,876Medicare Part D Prescriptions Filled, Including Refills

Rank: 412 out of 2456

$940K Total Retail Price of All Prescriptions

Rank: 42 out of 2456

447 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 447 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 447 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 3,634 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$137 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 269 195 1 2
OMEPRAZOLE 213 113 2 3
LISINOPRIL 204 119 3 1
GABAPENTIN 180 60 4 16
OXYCODONE HCL 159 25 S2 5 38
LEVOTHYROXINE SODIUM 148 108 6 4
CITALOPRAM HBR 142 116 7 14
ZOLPIDEM TARTRATE 123 36 8 28
ATORVASTATIN CALCIUM 121 94 9 12
FUROSEMIDE 114 95 10 8
SUBOXONE 114 0 10 62
METFORMIN HCL 113 71 12 11
HYDROCODONE-ACETAMINOPHEN 107 19 S3 13 20
FLUTICASONE PROPIONATE 103 49 14 30
METOPROLOL TARTRATE 100 81 15 10
TRUVADA 89 0 16 145
ATENOLOL 86 74 17 6
PROAIR HFA 82 31 18 22
AMLODIPINE BESYLATE 82 47 18 5
TRAMADOL HCL 75 43 20 24
LOSARTAN POTASSIUM 74 54 21 18
METOPROLOL SUCCINATE 73 35 22 13
NORVIR 63 0 23 151
HYDROCHLOROTHIAZIDE 62 51 24 7
MORPHINE SULFATE ER 59 0 S2 25 98
BUPROPION XL 57 17 26 271
IBUPROFEN 54 0 27 52
RISPERIDONE 54 54 27 50
METHADONE HCL 53 0 S2 29 135
ISENTRESS 52 0 30 215
DONEPEZIL HCL 51 51 31 23
PANTOPRAZOLE SODIUM 51 16 31 37
ADVAIR DISKUS 50 29 33 36
PREZISTA 50 0 33 218
NAPROXEN 50 38 33 109
FLUOXETINE HCL 50 29 33 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.